In addition, it remains true that TP53 is the most common somatic mutation in cancer and is particularly prevalent in cancers such as non-small cell lung cancer, in head and neck cancers and in many recurrent/refractory cancers such as testicular cancer. The gene discussed is TP53; the disease is cancer.